Why the White Pages of the Internet Matters to Public Health
This week, members of the Coalition for a Secure and Transparent Internet (CSTI) – including NABP – will virtually take to Capitol Hill to meet with members of Congress to discuss restoring access to WHOIS data. NABP and other CSTI members will speak with congressional staff about how essential this data is to law enforcement […]
Read More ›Countdown Clock Begins on Importation Rule Enactment
Following an expeditious review by the White House Office of Management and Budget, Food and Drug Administration (FDA) formally published its final rule regarding Importation of Prescription Drugs in the Federal Register on Thursday, October 1, 2020. The publication of the final rule starts the 60-day formal notice-and-comment period before the rule becomes effective on Monday, November 30. The […]
Read More ›White House Completes Review of Importation Final Rule
On Thursday, September 10, Food and Drug Administration (FDA) sent a proposed final rule to the White House Office of Management and Budget (OMB) for review that would set in motion components of the long-awaited Safe Importation Action Plan released in July 2019. Completion of this final rule has been a long-standing priority for FDA and the […]
Read More ›Online Platform Scrutiny Continues as Congress Reviews Section 230
As has been reported extensively over the last several months, the coronavirus disease 2019 (COVID-19) pandemic has presented an opportunity for criminals to leverage international fear and uncertainty for profit. Even predating the declaration of a national health emergency by the Trump Administration in March 2020, the United States Food and Drug Administration (FDA) and […]
Read More ›Pharmacy Community Pulls Together To Combat COVID-19
Challenging government and civil society at all levels, the COVID-19 pandemic has tested the ability of public officials, local and federal agencies, health care entities, and numerous other stakeholders to act quickly and effectively in a public health crisis. Because pharmacists play such an important role as frontline and accessible health care providers, numerous organizations […]
Read More ›How Washington’s Response to COVID-19 Impacts Pharmacy Practice
As the nation and the world contended with the emergence and spread of COVID-19 this spring, policymakers in Washington responded with unprecedented speed by enacting and implementing multiple sweeping laws and regulations to combat the virus. From major cash assistance for businesses and individuals to sweeping healthcare reforms, the COVID-19 public health emergency drove policies […]
Read More ›Unclear CBD Legislation Keeps Regulators on Edge
Since the passage of the 2018 Farm Bill, CBD-infused food and drink products have taken the marketplace by storm. You’ve probably seen it yourself in the grocery store – shelves featuring chocolate, tea, candy, and other edibles containing cannabidiol. These products are often impermissibly marketed to treat everything from anxiety to joint pain to cancer. […]
Read More ›Increasing Access to Naloxone Can Be a Lifeline in the Community
If it weren’t for naloxone, many Americans would not be alive today. From 1996 to June 2014, at least 26,000 opioid overdoses were reversed with naloxone provided by community-based organizations. Naloxone access laws correlate with a 9 to 11 percent reduction in opioid-related deaths by state. In 2017, 70,237 Americans died from drug overdoses, and […]
Read More ›Arkansas Inspector Ensures Pharmacies Are Up to Code
Inspectors/investigators are the eyes and ears for boards of pharmacy, ensuring compliance with pharmacy law and practice standards. In this feature, inspectors reveal what they’ve learned in the field. Kevin Robertson, PharmD, PD, BCPS Inspector/Investigator, Arkansas State Board of Pharmacy How long have you been serving as an inspector for the Board? What was your […]
Read More ›